BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 22649197)

  • 1. Donor B cells in transplants augment clonal expansion and survival of pathogenic CD4+ T cells that mediate autoimmune-like chronic graft-versus-host disease.
    Young JS; Wu T; Chen Y; Zhao D; Liu H; Yi T; Johnston H; Racine J; Li X; Wang A; Todorov I; Zeng D
    J Immunol; 2012 Jul; 189(1):222-33. PubMed ID: 22649197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloimmune response results in expansion of autoreactive donor CD4+ T cells in transplants that can mediate chronic graft-versus-host disease.
    Zhao D; Young JS; Chen YH; Shen E; Yi T; Todorov I; Chu PG; Forman SJ; Zeng D
    J Immunol; 2011 Jan; 186(2):856-68. PubMed ID: 21149609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.
    Wu T; Young JS; Johnston H; Ni X; Deng R; Racine J; Wang M; Wang A; Todorov I; Wang J; Zeng D
    J Immunol; 2013 Jul; 191(1):488-99. PubMed ID: 23709681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice.
    Jin H; Ni X; Deng R; Song Q; Young J; Cassady K; Zhang M; Forman S; Martin PJ; Liu Q; Zeng D
    Blood; 2016 May; 127(18):2249-60. PubMed ID: 26884373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
    Zhang C; Todorov I; Zhang Z; Liu Y; Kandeel F; Forman S; Strober S; Zeng D
    Blood; 2006 Apr; 107(7):2993-3001. PubMed ID: 16352808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-21 promotes lupus-like disease in chronic graft-versus-host disease through both CD4 T cell- and B cell-intrinsic mechanisms.
    Nguyen V; Luzina I; Rus H; Tegla C; Chen C; Rus V
    J Immunol; 2012 Jul; 189(2):1081-93. PubMed ID: 22723520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrafollicular CD4
    Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
    Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.
    Yi T; Chen Y; Wang L; Du G; Huang D; Zhao D; Johnston H; Young J; Todorov I; Umetsu DT; Chen L; Iwakura Y; Kandeel F; Forman S; Zeng D
    Blood; 2009 Oct; 114(14):3101-12. PubMed ID: 19602708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity.
    Kong X; Zeng D; Wu X; Wang B; Yang S; Song Q; Zhu Y; Salas M; Qin H; Nasri U; Haas KM; Riggs AD; Nakamura R; Martin PJ; Huang A; Zeng D
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32931481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target antigens determine graft-versus-host disease phenotype.
    Kaplan DH; Anderson BE; McNiff JM; Jain D; Shlomchik MJ; Shlomchik WD
    J Immunol; 2004 Nov; 173(9):5467-75. PubMed ID: 15494494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells, murine chronic graft-versus-host disease and autoimmunity.
    Eisenberg RA; Via CS
    J Autoimmun; 2012 Sep; 39(3):240-7. PubMed ID: 22704961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects.
    Johnston HF; Xu Y; Racine JJ; Cassady K; Ni X; Wu T; Chan A; Forman S; Zeng D
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1089-103. PubMed ID: 24796279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
    Anderson BE; McNiff JM; Matte C; Athanasiadis I; Shlomchik WD; Shlomchik MJ
    Blood; 2004 Sep; 104(5):1565-73. PubMed ID: 15150080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
    Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.
    Ohnuma K; Hatano R; Aune TM; Otsuka H; Iwata S; Dang NH; Yamada T; Morimoto C
    J Immunol; 2015 Apr; 194(8):3697-712. PubMed ID: 25786689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
    Zhang Y; Hexner E; Frank D; Emerson SG
    J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients.
    Yi T; Li X; Yao S; Wang L; Chen Y; Zhao D; Johnston HF; Young JS; Liu H; Todorov I; Forman SJ; Chen L; Zeng D
    J Immunol; 2011 Mar; 186(5):2739-49. PubMed ID: 21263067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.
    Hurchla MA; Sedy JR; Murphy KM
    J Immunol; 2007 May; 178(10):6073-82. PubMed ID: 17475832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.